Immutep Limited (ASX:IMM) CEO and Executive Director Marc Voigt reflects on a year marked by promising clinical trial results and a landmark partnership with Merck. He highlights progress in developing treatments for autoimmune diseases and anticipates milestones for the year ahead.
Copyright 2024 – Finance News Network
01 Aug 2024 - Santana Minerals Limited (ASX:SMI) Executive Director Sam Smith provides an update on the company, discussing the latest high-grade drill results from the Rise and Shine deposit and commenting on the company's recent listing on the New Zealand Stock Exchange.
12 Aug 2020 - Galan Lithium Limited (ASX:GLN) Managing Director, Juan Pablo Vargas de la Vega talks about the company's lithium brine projects located within the South American Lithium Triangle in Argentina strategy and near-term targets.
2 Aug 2022 - Laybuy Holdings Limited (ASX:LBY) Co-Founder and Managing Director Gary Rohloff discusses quarterly results, restructuring of the company and outlook.
11 Dec 2020 - Novatti Group Limited (ASX:NOV) Managing Director Peter Cook discusses the company's strategy of partnering with Tier 1 companies, including Ripple, Google Pay and Samsung Pay.
26 Apr 2021 - Praemium Limited (ASX:PPS) CEO and Managing Director Michael Ohanessian talks about the company's strong 1H21 results, the successful acquisition of Powerwrap, platform enhancements and outlook.
30 Jul 2024 - Immutep Limited (ASX:IMM) CEO and Executive Director Marc Voigt discusses Phase III design for a trial in non-small cell lung cancer, positive results in head and neck cancer, and clearance for a Phase I study in autoimmune diseases.
22 Jun 2023 - Magnis Energy Technologies Limited (ASX:MNS) Managing Director (US) Hoshi Daruwalla discusses the UN/DOT 38.3 certification awarded to lithium-ion batteries produced at the IM3NY battery plant.